China Pharma Holdings (CPHI) Buildings (2011 - 2023)

China Pharma Holdings' Buildings history runs 13 years deep, the most recent figure standing at $9.1 million for Q2 2023.

• Quarterly Buildings fell 7.12% year-over-year to $9.1 million in Q2 2023, while the trailing twelve-month figure through Jun 2023 was $9.1 million (down 7.12% YoY) and the FY2022 annual result came in at $9.4 million, down 8.46% from the prior year.
• Buildings was $9.1 million for Q2 2023 at China Pharma Holdings, down from $9.5 million in the prior quarter.
• Across five years, Buildings topped out at $10.3 million in Q1 2022 and bottomed at $9.1 million in Q2 2023.
• A 5-year average of $9.7 million and a median of $9.6 million in 2020 frame the typical range for Buildings.
• Annual changes were most pronounced in 2021 — Buildings grew 9.59% — and 2022, when it fell 8.65%.
• China Pharma Holdings' Buildings stood at $9.4 million in 2019, then increased by 6.92% to $10.0 million in 2020, then climbed by 2.34% to $10.3 million in 2021, then slipped by 8.46% to $9.4 million in 2022, then decreased by 3.61% to $9.1 million in 2023.
• Business Quant data shows CPHI's Buildings at $9.1 million in Q2 2023, $9.5 million in Q1 2023, and $9.4 million in Q4 2022.